Search | Page 37 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Recurrent and Secondary MDS

    ... after medical treatments, and even after an allogeneic stem cell transplant . So, I think of recurrent MDS to mean progression or ... low blood counts, and at times, we see a population of MDS cells that can develop. This may also occur related to other bone marrow ...

    Interview last updated 10/24/2012 - 1:12pm.

  2. T-cell Depleted Alternative Donor Transplantation

    ... disease (GVHD) in patients receiving a stem cell transplant from an alternative (unrelated and mismatched related) ... and post-transplant infections. Patients requiring stem cell transplants for either malignant (cancerous) or non-malignant disease ... Device: CliniMACS® (T cell depletion) Stem cells will be collected from donors after they receive Granulocyte ...

    Clinical Trial last updated 04/29/2016 - 3:38pm.

  3. Medical Resources

    ... education & awareness about using umbilical cord blood stem cells as a treatment for disease. Salute To Life ...

    Page last updated 08/20/2015 - 8:34am.

  4. Related Diseases

    ... cancer that occurs when young abnormal white blood cells (leukemia cells) start to fill up the bone marrow and interfere with the ... versus host disease (GVHD) is a common complication of a stem cell/ bone marrow transplant . It happens when the donor's immune ...

    Page last updated 07/07/2016 - 3:16pm.

  5. Acute Myeloid Leukemia (AML)

    ... a blood cancer. It happens when young abnormal white blood cells called blasts (leukemia cells), begin to fill up the bone ... an anthracycline (such as daunorubicin or idarubicin). Stem cell transplantation may be used after chemotherapy as a second phase of ...

    Topic section last updated 07/07/2016 - 3:15pm.

  6. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... RATIONALE: A peripheral stem cell transplant may be able to replace blood-forming cells that were destroyed by chemotherapy and radiation therapy, or ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  7. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells in conjunction with the immunomodulating drug, ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  8. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... RATIONALE: Midostaurin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in ... patients who have received prior autologous or allogeneic stem cell transplantation are not eligible; patients may have received 1 or 2 ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  9. Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

    ... with hematologic malignancies undergoing hematopoietic stem cell transplant (HSCT). Biological therapies, such as sirolimus and ... suppress the immune system in different ways and stop tumor cells from growing. Giving sirolimus and mycophenolate mofetil after ...

    Clinical Trial last updated 05/03/2016 - 11:35am.

  10. Issues for Parents of Pediatric Bone Marrow Failure Patients

    ... does a doctor decide if a child is a good candidate for a stem cell transplantation? DR. MARGOLIS: We will call it a bone ... for lack of a better word. You can get your blood stem cells from either bone marrow, cord blood, or peripheral blood, and there ...

    Page last updated 06/20/2011 - 12:10pm.